Port removal in patients receiving emicizumab prophylaxis: A single centre experience and review of the literature
Sign Up to like & getrecommendations! Published in 2021 at "Haemophilia"
DOI: 10.1111/hae.14459
Abstract: Treatment of patients with Haemophilia A has improved significantly in recent years since the advent of novel therapeutic agents such as emicizumab. The low annualised bleeding rates associated with emicizumab have liberated many patients from… read more here.
Keywords: emicizumab prophylaxis; receiving emicizumab; removal; removal patients ... See more keywords